Heart disease is a lifelong condition for most patients. In order to sustain their lives, they require either:
Donor hearts are scarce in Singapore therefore many of these patients need to be fitted with a mechanical heart assist device (an artificial heart) as a last resort. The device helps patients in the following ways by:
According to records, young patients at only 14 years old have been fitted with a
mechanical heart assist device. The device costs around
S$160,000 before subsidy, and financially needy patients have to rely on your generosity through the NHCS Heart To Heart Fund for support.
Patients who are at high risk of
sudden cardiac death also benefit from the Heart To Heart Fund. Patients usually go through this process:
Fortunately, such tragedies can be prevented with the
implantable cardiac defibrillators (ICDs) that are designed to restore a heart’s normal rhythm with a small electric shock. The cost of an ICD ranges from
S$7,000 onwards before subsidy, and your kind support to the NHCS Heart To Heart Fund will help save more patients from sudden cardiac death.
Research takes time and resources to bloom into meaningful discoveries that will one day become revolutionary treatments for heart disease.
An estimated S$2 million is needed each year to drive our research efforts in cardiovascular medicine. NHCS’ research arm, the
National Heart Research Institute Singapore, aims to shed light on how heart disease and their treatments work on Asian patients as current research literature mainly focuses on Caucasian populations.
One of the key areas our research scientists are working on is the
study of inherited cardiac conditions that lead to heart failure and sudden cardiac death. The findings will help in the creation of better diagnostics and treatments for these heart conditions which tend to strike younger patients. These research breakthroughs will potentially save many young precious lives from dying from premature deaths.
Subscribe to our mailing list to get the updates to your email inbox...